Compass Therapeutics Inc. logo

Compass Therapeutics Inc.

We are developing next-generation antibodies into transformative cancer therapies that improve patients’ lives.

57 employees · est. 2014 · Boston, United States

VS
Tarveda Therapeutics logo

Tarveda Therapeutics

To discover, develop and commercialize a new class of potent and selective precision oncology medicines.

5 employees · est. 2011 · Watertown, United States

Tarveda Therapeutics is the older company (2014 vs 2011); Compass Therapeutics Inc. is the larger of the two.

Side-by-Side Comparison

Compass Therapeutics Inc. Tarveda Therapeutics
Founded
2014 2011 older
Headquarters
Boston, United States Watertown, United States
Employees
57 larger 5
Industry
Biopharma, Biotechnology, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
IPO Unknown
Total Funding
$500.96M $119.80M
Funding Rounds
11 7
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical Company, Oncology-focused, Antibody-based Therapeutics, Cancer Therapies, Angiogenesis, Tumor Growth, Immunotherapy, Clinical-stage, Proprietary Pipeline Antibodies, Immunosuppressive Mechanisms, Combination Therapies, Microvasculature Modulation, Effector Cells, Immune Surveillance, Boston Precision Oncology, Biopharmaceuticals, Drug Development, Solid Tumor Treatment, Miniature Drug Conjugates, Pentarin Technology, Targeted Cancer Therapy, HSP90 Binding, Topoisomerase 1 Inhibitor, Phase 2a Clinical Trials, Cancer Payload Delivery, Somatostatin Receptor 2 Therapy, Kinase Inhibitors, Radioisotope Drug Conjugates, Neuroendocrine Tumor Treatment
Website
compasstherapeutics.com tarvedatx.com
Compass Therapeutics Inc. logo

About Compass Therapeutics Inc.

Compass Therapeutics Inc. is a clinical-stage, oncology-focused biopharmaceutical company that aims to develop next-generation antibodies into transformative cancer therapies, ultimately improving patients’ lives. The company's scientific focus is on the relationship between angiogenesis, the immune...

Tarveda Therapeutics logo

About Tarveda Therapeutics

Tarveda Therapeutics, founded in 2011, is a clinical-stage biopharmaceutical company focused on developing a new class of potent and selective precision oncology medicines. Its cutting-edge technology, branded as Pentarin® miniature drug conjugates, targets solid tumor malignancies. These conjugates...

We will tell you when either one moves

BounceWatch watches Compass Therapeutics Inc. and Tarveda Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Compass Therapeutics I... and Tarveda Therapeutics — by email.

Frequently Asked Questions

Compass Therapeutics Inc. — We are developing next-generation antibodies into transformative cancer therapies that improve patients’ lives.. Tarveda Therapeutics — To discover, develop and commercialize a new class of potent and selective precision oncology medicines. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Compass Therapeutics Inc. has raised $500.96M while Tarveda Therapeutics has raised $119.80M.
Compass Therapeutics Inc. and Tarveda Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Compass Therapeutics Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Compass Therapeutics Inc. on 9 Jun 2026, and Tarveda Therapeutics on 13 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes